EP009 (EP-009; EP 009) is a novel, orally bioactive and selective inhibitor of JAK3 with potential antitumor activity. It inhibits JAK3 with an IC50 of 10-20 uM in cell-based assays.

纯度：≥98%

CAS：1462951-30-9